Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmadrug Inc
C.PHRX
Alternate Symbol(s):
LMLLF
Medical Care
Cannabis
PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural...
medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases and rare cancers. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions. The Company also operates through SecureDose Synthetics Inc., which is a pharmaceutical research and development company focused on the development of synthetic formulations of existing drugs for potential commercialization and distribution.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(6)
•••
davwal
X
View Profile
View Bullboard History
Comment by
davwal
on May 17, 2022 2:29am
RE:When we going to get news about cep for covid?
thanks for the link
(1)
•••
Lookatmenow77
X
View Profile
View Bullboard History
Post by
Lookatmenow77
on May 16, 2022 3:48pm
When we going to get news about cep for covid?
https://news.cgtn.com/news/2022-05-13/China-grants-patent-to-new-COVID-19-medicine-1a0tTh07obe/index.html
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(24)
•••
BMcCutcheon
X
View Profile
View Bullboard History
Post by
BMcCutcheon
on May 03, 2022 2:36pm
Pharmadrug advances opthalmology program
Pharmadrug advances opthalmology program
(1)
•••
Hammer1
X
View Profile
View Bullboard History
Post by
Hammer1
on May 03, 2022 8:19am
News
https://stockhouse.com/news/press-releases/2022/05/03/pharmadrug-advances-opthalmology-program-with-final-selection-of-lead-dmt
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Post by
Blahblahblahbla
on Apr 11, 2022 6:39pm
Looks like more news coming soon
PharmaDrug advances DMT-analogue glaucoma program with fabrication of medical device PharmaDrug Inc CEO Daniel Cohen tells Proactive it has successfully completed the fabrication of
...more
(17)
•••
SuperTrader1
X
View Profile
View Bullboard History
Comment by
SuperTrader1
on Apr 10, 2022 5:00pm
RE:RE:PharmaDrug Advances DMT-Analogue Program for Glaucoma
American Investors are now moving in, see movement in next week. $THRX will be a Wimmer!
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Comment by
Blahblahblahbla
on Apr 09, 2022 4:36pm
RE:PharmaDrug Advances DMT-Analogue Program for Glaucoma
Exciting times for shareholders. Everything moving forward and into place nicely.
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Apr 07, 2022 8:29am
PharmaDrug Advances DMT-Analogue Program for Glaucoma
PharmaDrug Advances DMT-Analogue Program for Glaucoma with Production of Medical Device Designed to Provide Sustained Control of Elevated Intraocular Pressure 2022-04-07 07:31 ET -
...more
(17)
•••
SuperTrader1
X
View Profile
View Bullboard History
Post by
SuperTrader1
on Apr 06, 2022 4:10pm
10-12?
I weant to see some Maga Power
(3214)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Apr 01, 2022 8:28am
Pharmadrug Advances PD-001
Committed to the 'pipeline-in-a-pill' approach with PD-001 for certain cancers and COVID-19 Advances cGMP manufacturing of clinical drug supply with Southwest Research Institute
...more
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Mar 03, 2022 12:46pm
Just noticed
there's some increased volume, & an uptick in the PPS.
(11)
•••
swim
X
View Profile
View Bullboard History
Post by
swim
on Feb 23, 2022 8:40am
PharmaDrug Receives Positive Results for DMT-Analogue Progra
PharmaDrug receives encouraging potency data for candidate DMT-analogue molecules designed to treat primary open angle glaucoma Terasaki Institute advances PharmaDrug's candidate DMT-analogue
...more
(38)
•••
Blahblahblahbla
X
View Profile
View Bullboard History
Post by
Blahblahblahbla
on Feb 01, 2022 7:48am
Great News Release today
News Press Releases PharmaDrug Announces Filing of US Provisional Patent for Cepharanthine to Treat Prostate Cancer C.PHRX | 16 minutes
...more
(3076)
•••
Goldy63
X
View Profile
View Bullboard History
Comment by
Goldy63
on Jan 26, 2022 1:00pm
RE:PharmaDrug Announces Initiation of Manufacturing of Cepharan
Getting very interesting here . Drugs to treat a whole host of medical problems . Love It. Cepharanthine has been shown to exhibit multiple pharmacological properties including anti-oxidative, anti
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden